This aspect of the findings makes the study increasingly significant, and present a scenario in which one could consider therapeutic targeting of PARP9 signaling to treat virus infection and avoid enhancing an inflammatory cytokine storm. This evidence concerns the gene PARP9 and viral infectious disease.